CTOs on the Move

Radioisotope Life Sciences

www.rls.bio

 
RLS (Radioisotope Life Sciences), the third-largest nuclear medicine pharmacy network in the United States, owns and operates 31 radiopharmacies across 18 states, offering an extensive portfolio of molecular imaging products. We endeavor to supply the highest quality radiopharmaceuticals in the industry by dispensing 100 percent of injectable unit dose products in clean rooms built to ISO 1644-1 specifications. In support of our commitment to quality, we provide tailored solutions and exceptional service to our more than 1500 customers.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.rls.bio
  • 801 International Parkway Suite 5092
    Lake Mary, FL USA 32746
  • Phone: 813.285.3065

Executives

Name Title Contact Details

Similar Companies

Pieris

Pieris Pharmaceuticals is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. Our pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Proprietary to Pieris, Anticalin proteins are a novel class of therapeutics validated in the clinic and by partnerships with leading pharmaceutical companies. Pieris is listed on the NASDAQ and trades under the ticker symbol PIRS.

Panacea Pharmaceuticals

Panacea Pharmaceuticals is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Modigene

Modigene Inc. is a Vienna, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lighthouse Behavioral Health Solutions

Substance Use Disorder and Mental Health Residential, Outpatient and Recovery Housing. Accepts all Medicaid. Holistic 360’ approach.

Novadoz

Novadoz Pharmaceuticals is a sales and marketing subsidiary for MSN Labs portfolio of finished dosage forms. MSN Labs is a global leader in the development and manufacturing of APIs (active pharmaceutical ingredients).